SCHEMBL25429983

SCHEMBL25429983

O=C(CNS(=O)(=O)C(F)(F)F)N1CCc2ccc(Oc3ccc(C(F)(F)F)c(F)c3)cc2C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ ESR1 P03372 2/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ TP53 P04637 1/20 0.37
▸ DRD2 P14416 2/20 0.37
▸ DRD3 P35462 2/20 0.37
▸ KDM1A O60341 3/20 0.36
▸ HDAC6 Q9UBN7 3/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ ABHD6 Q9BV23 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30519250 1.00 NPC1 (0.42) NPC1RAB9AL3MBTL1ALDH1A1PKM
SCHEMBL31565827 0.88 L3MBTL1 (0.41) NPC1RAB9AL3MBTL1ALDH1A1PKM
SCHEMBL31566065 0.88 NPC1 (0.40) NPC1RAB9AL3MBTL1ALDH1A1PKM
SCHEMBL25430398 0.87 L3MBTL1 (0.42) NPC1RAB9AL3MBTL1ALDH1A1ESR1
SCHEMBL31565972 0.86 L3MBTL1 (0.42) NPC1RAB9AL3MBTL1ALDH1A1ESR1
SCHEMBL30519194 0.84 ESR1 (0.42) L3MBTL1ALDH1A1ESR1ESR2TP53
SCHEMBL25429255 0.84 ESR1 (0.42) L3MBTL1ALDH1A1ESR1ESR2TP53
SCHEMBL31565932 0.84 ALDH1A1 (0.47) L3MBTL1ALDH1A1ESR1ESR2TP53
SCHEMBL31565856 0.83 L3MBTL1 (0.40) NPC1RAB9AL3MBTL1ALDH1A1ESR1
SCHEMBL25428445 0.83 ALDH1A1 (0.41) NPC1RAB9AL3MBTL1ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147063-A2 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2023-08-03 — — WO disclosed
Send feedback